Emerging Therapies for IgA Nephropathy
medcases00
Published on Nov 29, 2022
Atrasentan and BION-1301 - An Interim Analyses from ERA 2022
Dr. Dana Rizk
Professor of Medicine
University of Alabama at Birmingham
Dr. Sreedhar Mandayam
Professor of Medicine
University of Texas
MD Anderson Cancer Center
Dr. Andrew King
Chief Scientific Officer
Chinook Therapeutics
www.glomcon.org
www.edu.glomcon.org
www.pubs.glomcon.org
Category
Tags
- Your Subscription
- medcases00 -
Share Video
Add to
Please Sign In or Create Account to use this feature!
Flag Video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Rate video
Please Sign In or Create Account to use this feature!
Up next
Autoplay
Autoplay
Recommended
-
KDIGO Management of Hyperkalemia: New Guidance, Emerging Evidence, and Changing Therapies
14 views 1296 days ago -
Emerging Therapies for Managing Complement 3 Glomerulopathy
15 views 788 days ago -
The Role of the Complement System in IgA Nephropathy, C3G, & Membranous Nephropathy
15 views 800 days ago -
IgA Nephropathy - Fellow's Level Overview of Basic Pathophysiology and Treatment
17 views 1296 days ago -
Clinical Trial Series: IgA Nephropathy
14 views 1294 days ago -
The Pathogenesis of IgA Nephropathy and Future Treatment Options. ft Dana Rizk, MD
15 views 832 days ago -
"Updates in IgA Nephropathy" presented by Natalie Beck, MD
14 views 814 days ago -
NephCure U: IgA Nephropathy
13 views 800 days ago -
New and Emerging Nephrotoxins - J. King
13 views 1073 days ago -
Updates in LN: New Era of Therapies with Dr. Alfred Kim
16 views 1045 days ago